Waterfront Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Waterfront Wealth's BMY Position: Q1 2026 in Review
Waterfront Wealth increased its Bristol-Myers Squibb (BMY) stake by 4.5% in Q1 2026, buying an estimated $82.4K and bringing the position to 33,159 shares worth $2.01M. The position accounts for 0.37% of the portfolio, ranked #85.
Waterfront Wealth first reported a position in BMY in Q2 2021 and has held it in 12 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Waterfront Wealth held 33,159 shares of Bristol-Myers Squibb worth $2.01M as of Q1 2026.
- Waterfront Wealth bought 1,414 Bristol-Myers Squibb shares in Q1 2026, an estimated $82.4K.
- Bristol-Myers Squibb made up 0.37% of Waterfront Wealth's portfolio in Q1 2026, its #85 holding.
- Waterfront Wealth first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 12 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Waterfront Wealth's 13F filing for Q1 2026, filed 30 Apr 2026.